Skip to content

Role of Homoeopathic Medicine on Primary Dysmenorrhoea

Effect of Individualized Homoeopathic Medicine on Pain Intensity and Quality of Life in Patients with Primary Dysmenorrhoea Using Kent’s Repertory: A Single Group Pre-Post Interventional Study - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077150
Enrollment
42
Registered
2024-11-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Intervention1: Individualized Homoeopathic Medicine: Intervention is planned as administering of indicated homoeopathic medicine in centesimal potency on the basis of individualization. Each dose will

Sponsors

Dr Santana Maity
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Female aged between 12 to 30 years presenting with typical history of Primary Dysmenorrhoea Female patients who are suffering from atleast 6 months with spasmodic pain of sufficient magnitude during menses lasting not more than 72 hours, without any diagnosed ovarian or uterine pathology. Patients willing to give written consent/assent to participate in the study

Exclusion criteria

Exclusion criteria: Diagnosed or suspected cases of secondary dysmenorrhea due to any abnormal pelvic pathology in Ultrasonography of lower abdomen. Patients having unevaluated gynaecological abnormalities; e.g. unexplained vaginal bleeding, cervical dysplasia, pelvic inflammatory diseases within one month. Patients using oral contraceptive pills, hormone replacement therapy or corticosteroids or having a history of their use in previous 3 months Diagnosed cases of uncontrolled systemic diseases, unstable psychiatric illness or other life-threatening illnesses or any vital organ failure. Undergoing any homoeopathic treatment for a chronic condition(s) within last 1 month. Substance abuse and/or dependence

Design outcomes

Primary

MeasureTime frame
WaLIDD score for assessing severity of pain during Primary DysmenorrhoeaTimepoint: Each patient will get follow-up for at least 3 months at the interval of 1 month

Secondary

MeasureTime frame
EQ-5D-5L questionnaire for assessing the impact on quality of lifeTimepoint: Each patient will get follow-up for at least 3 months at the interval of 1 month

Countries

India

Contacts

Public ContactDr Purnendu Ash

Mahesh Bhattacharyya Homoeopathic Medical College and Hospital

purnendubhms29@gmail.com9051420436

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026